Virometix

Virometix AG is a Swiss biotechnology company, a privately-owned entity dedicated to developing a new generation of vaccines and immunotherapeutics for the prevention and treatment of infections and cancer. In an increasingly globalized world, there is significant medical demand for vaccines to combat infectious diseases as well as many chronic human conditions, including cancer. Rational molecular design, chemical synthesis, and Virometix's proprietary "synthetic virus-like particle" platform technology enable the rapid production and optimization of vaccine candidates, with the potential to exhibit superior performance in terms of safety, efficacy, and stability.